ISLAMABAD – Phase-III of clinical trials of a Chinese Coronavirus candidatevaccine will be organized in Pakistan later this month.
It has been revealed by the Parliamentary Secretary, National HealthServices Regulations and Coordination, Nausheen Hamid.——————————
According to details, China National Pharmaceutical Group (Sinopharm) hasdeveloped the inactivated COVID-19 vaccine, Phase-I and –II clinical trialsof which have already been successfully concluded in China.
On 15 September, Sinopharm will supply the Coronavirus vaccine to theNational Institute of Health (NIH) for Phase-III clinical trials which willstart from 20 September.
Read Top Stories
In this regard, healthcare specialists linked with NIH are being providedwith proper training.——————————
Sinopharm is carrying out Phase-III clinical trials simultaneously inseveral countries because the number of active Coronavirus cases in Chinais simply insufficient to comprehensively assess the vaccine.
